GPC3-based circular RNA vaccine (First Affiliated Hospital Of Zhejiang University)

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug NameGPC3-based circular RNA vaccine (First Affiliated Hospital Of Zhejiang University)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > Circular RNA vaccine

Mechanisms of ActionGlypican-3 modulators

TargetsGlypican-3

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesFirst Affiliated Hospital Of Zhejiang University

China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Zhejiang University

Inactive CompaniesN/A

Active IndicationsCarcinoma, Hepatocellular

Inactive IndicationsN/A

Other Information

ATC CodeN/A